Expert Radar
Dr. Mahyar Etminan, MSc, PharmD
Principal, Epilytics (Vancouver, CA)
Bachelor of Science, University of British Columbia
Dr. Mahyar Etiminan has 18 years of experience in the fields of Pharmacology and Epidemiology. He earned his BS in Pharmacy from the University of British Columbia, MS in Clinical Epidemiology from the University of Toronto, and his Pharm.D. in Clinical Pharmacology from the Idaho State University L. S. Skaggs College of Pharmacy. Formerly, this expert served as an Assistant Professor at the University of British Columbia Faculty of Medicine. He currently serves as an Associate Professor and as a Scientist at the University of British Columbia Faculty of Medicine. He is also the Principal of EpiLytics.
e*********@m****.ubc
(778) ***-****
Vancouver, BC, British Columbia
Get a FREE Demo of Dr. Mahyar Etminan, MSc, PharmD's Radar Profile
Review this expert's litigation history, supporting legal docs, publications, professional background, and more.
Comprehensive data on expert witnesses: Access detailed litigation history and performance metrics.
Swift assessment: Quickly evaluate an expert's track record.
Informed decisions: Make better choices when selecting or challenging expert witnesses in any case.
DISCLAIMER: Expert Institute operates independently and objectively as an expert witness data provider. This listing does not reflect or imply any existing relationship between the expert and Expert Institute. We do not employ, endorse, or maintain any affiliation with the experts listed. Information shown is automatically generated from public sources and may not be current or complete. For verified, in-depth expert data, please contact us to initiate a formal request.
Expert Witness Activity
12
Plaintiff Cases
13
Defense Cases
Expert Challenges
6
Deposition Transcripts
Publications
212
Media & News
1084
Social Media Mentions
30
Radar found 14 records
Case Name | Role | Filed Date |
|---|---|---|
Ellen Hutt, et al. v. Bristol-Myers Squibb Company, et al. | Expert Witness | 2021-08-18 |
Christopher Johnson, et al. v. Glenmark Pharmaceuticals, Inc. USA, et al. | Expert Witness | 2020-02-06 |
In re: Mirena IUS Levonorgestrel-Related Products Liability Litigation (No. II) | Expert Witness | 2017-04-13 |
Radar monitors both national and state court systems to track litigation activity and access court documents.
View case details, documents, plaintiff and defense representation, defendants, judges, jurisdiction, and more.

Defense
Plaintiff
0
25
50
75
100
2000
0
2002
0
2004
0
2006
0
2008
0
2010
0

0
25
50
75
100
Institution | Degree Type |
|---|---|
University of British Columbia | Bachelor of Science |
Idaho State University L. S. Skaggs College of Pharmacy | Doctor of Pharmacy |
University of Toronto | Master of Science |
Title | Employer |
|---|---|
Principal | Epilytics (Vancouver, CA) |
Associate Professor | University of British Columbia Faculty of Medicine (Vancouver, CA) |
Scientist | University of British Columbia Faculty of Medicine (Vancouver, CA) |
Radar found 212 records
Title | Type |
|---|---|
Increased risk of pigmentary degeneration of the iris and pigmentary glaucoma with fluoroquinolone antibiotics | Journal Article |
A note on handling conditional missing values | Commentary |
Causal diagrams for disease latency bias | Journal Article |
Radar monitors a wide array of publication sources, including links to abstracts.
Review book chapters, journal articles, research papers, trade publications, technical reports, conference proceedings, and more.

Radar found 1084 records
Title | Description |
|---|
Radar scours thousands of media and news sources across the internet 24/7.
Access interviews, webinars, TV appearances, blog posts, columns, whitepapers, PDFs, profressional profiles, and more.

Access detailed litigation history and performance metrics.
Access your Radar profile through Expert iQ, our secure, cloud-based platform that hosts AI-driven insights.
Delivered in 5–7 business days
Receive your profile swiftly, with Radar gathering intelligence from thousands of data points.
24/7 monitoring for 12 months
Stay informed with continuous monitoring and live alerts, ensuring your profile is always up-to-date.

